The Diagnostic Workup: Ensuring a Complete Evaluation
Last updated:
A comprehensive Retinitis Pigmentosa (RP) diagnosis combines a physical eye exam, an ERG to measure the electrical activity of retinal cells, OCT scans to visualize retinal layers, and genetic testing to identify the exact gene mutation causing the vision loss.
Key Takeaways
- • A complete RP diagnostic workup establishes a vital baseline to monitor how your eye health changes over time.
- • Doctors perform a fundus exam to look for the classic triad of RP: bone spicules, optic nerve pallor, and vessel attenuation.
- • The Full-field ERG is the definitive test for measuring the electrical function of your light-sensing cells.
- • OCT scans are used to track the health of remaining photoreceptors and identify treatable retinal swelling (CME).
- • Genetic testing is critical to confirm your specific gene mutation, determine inheritance risks, and check clinical trial eligibility.
Diagnosing Retinitis Pigmentosa (RP) is a multi-step process that combines high-tech imaging, electrical testing, and genetic analysis. A complete clinical workup is essential because it not only confirms the diagnosis but also establishes a “baseline”—a snapshot of your eye’s health that allows your doctor to monitor changes over time [1][2].
The Physical Exam: What the Doctor Sees
When a specialist looks into the back of your eye (the fundus), they are searching for a specific set of markers known as the “classic triad” of RP [3]:
- Bone Spicules: These are small, dark pigment deposits that look like tiny branches or spider legs. They occur when pigment cells from a deeper layer of the eye migrate into the retina as the photoreceptor cells break down [4][5].
- Waxy Optic Nerve Pallor: The optic nerve is the cable that carries signals from the eye to the brain. In RP, this nerve can take on a pale, yellowish, “waxy” appearance [6].
- Vessel Attenuation: This is a medical term for the narrowing of the blood vessels in the retina. As the retina requires less oxygen because of cell loss, the blood vessels naturally become thinner [5].
The Essential Tests
Full-field ERG (The Electrical Test)
The Full-field Electroretinogram (ffERG) is the definitive test for RP. While a standard eye exam looks at the structure of the eye, the ERG measures its function [2]. It records the electrical response of your rods and cones to flashes of light. In RP, the ERG will typically show that the rods are much weaker than the cones, or in advanced cases, the electrical signal may be “extinguished” (too faint to measure) [5][7].
OCT (The Cross-Section Scan)
Optical Coherence Tomography (OCT) uses light waves to take a high-resolution, 3D picture of the layers of your retina. Doctors use it to monitor two critical things:
- Ellipsoid Zone (EZ) Line: This is a specific line on the scan that represents healthy, functioning photoreceptors. Measuring the width of this line is one of the best ways to track how much functional retina remains [8][9].
- CME (Swelling): Some patients with RP develop Cystoid Macular Edema, which is a buildup of fluid in the central part of the retina. This can cause blurriness that is often treatable [10].
Genetic Testing: The Key to the Future
Genetic testing is no longer “optional”—it is a critical part of a modern RP workup. It is the only way to confirm which of the 80+ known genes is causing your condition [11].
- Why it matters: Identifying your gene can tell you if you are eligible for current or upcoming clinical trials. It also helps differentiate inherited RP from “masqueraders” like infections or trauma that might only affect one eye (unilateral RP) [12].
- The Technology: Most doctors use Next-Generation Sequencing (NGS) to scan hundreds of genes at once. If this “panel” test is negative, more advanced tests like Whole-Genome Sequencing (WGS) can look at your entire genetic makeup to find rare or hidden mutations [13].
Your Completeness Checklist
If you are currently being evaluated, ensure your clinical record contains these data points:
- [ ] Nyctalopia (Night Blindness) History: A record of when your symptoms first began [3].
- [ ] Visual Field Test: A map of your peripheral vision (often called a “Goldmann” or “Humphrey” test) [14].
- [ ] Full-field ERG: The electrical confirmation of rod-cone dysfunction [2].
- [ ] OCT Scans: High-resolution images used to measure the “EZ line” and check for swelling (CME) [8].
- [ ] Genetic Testing: A report identifying your specific gene and inheritance pattern [4].
Frequently Asked Questions
What is the classic triad of retinitis pigmentosa?
Why do I need an ERG test to diagnose RP?
What does an OCT scan show during an RP evaluation?
Is genetic testing necessary if my doctor already suspects RP?
What are the next steps if my first genetic test is negative?
Questions for Your Doctor
- • Did my fundus exam show the 'classic triad' of RP findings: bone spicules, pale optic nerves, and narrowed vessels?
- • What did my ffERG results reveal about the current electrical activity of my rods compared to my cones?
- • Is the 'ellipsoid zone' (EZ) line still visible on my OCT scan, and can we measure its width to use as a baseline for the future?
- • If my first genetic test was negative or inconclusive, should we consider Whole-Genome Sequencing (WGS)?
Questions for You
- • Have you been tested for Vitamin A deficiency or had a history of eye trauma that might explain your symptoms?
- • Do you have a record of all your imaging (OCTs and fundus photos) to bring to future appointments for comparison?
- • Have you noticed any 'flashes' of light or 'shimmering' in your vision, which can sometimes occur with retinal changes or inflammation?
Want personalized information?
Type your question below to get evidence-based answers tailored to your situation.
References
- 1
Progressive RPE atrophy and photoreceptor death in KIZ-associated autosomal recessive retinitis pigmentosa.
Lin Y, Xu CL, Breazzano MP, et al.
Ophthalmic genetics 2020; (41(1)):26-30 doi:10.1080/13816810.2020.1723116.
PMID: 32052671 - 2
Progressive sector retinitis pigmentosa due to c.440G>T mutation in SAG in an Australian family.
Pappalardo J, Heath Jeffery RC, Thompson JA, et al.
Ophthalmic genetics 2021; (42(1)):62-70 doi:10.1080/13816810.2020.1832533.
PMID: 33047631 - 3
Introduction and Discovery of Retinitis Pigmentosa.
Wang HH, Chen N, Wang NK
Methods in molecular biology (Clifton, N.J.) 2023; (2560()):1-14 doi:10.1007/978-1-0716-2651-1_1.
PMID: 36481879 - 4
Bilateral Giant Choroidal Cavern in a Case of Rod-Cone Dystrophy: A Rare Presentation.
Shah R, Ajmani U, Nayak S, et al.
Ophthalmic surgery, lasers & imaging retina 2025; (56(4)):241-243 doi:10.3928/23258160-20241216-02.
PMID: 39960316 - 5
Retinitis Pigmentosa and Polydactyly in a Patient with a Heterozygous Mutation on the BBS1 Gene.
Guardiola G, Ramos F, Izquierdo N
International medical case reports journal 2021; (14()):459-463 doi:10.2147/IMCRJ.S321961.
PMID: 34262361 - 6
Ocular Toxoplasmosis Associated with Unilateral Pigmentary Retinopathy That May Mimic Retinitis Pigmentosa: Diagnostic Dilemmas.
Karska-Basta I, Romanowska-Dixon B, Pojda-Wilczek D, Mackiewicz N
Medicina (Kaunas, Lithuania) 2021; (57(9)) doi:10.3390/medicina57090892.
PMID: 34577815 - 7
Retained cone-responses in homozygous start codon variant in KIZ-associated retinitis pigmentosa.
Kong MD, O'Connell M, Exinor A, et al.
Documenta ophthalmologica. Advances in ophthalmology 2026; doi:10.1007/s10633-025-10066-7.
PMID: 41557064 - 8
Correlation of SD-OCT findings and visual function in patients with retinitis pigmentosa.
Battaglia Parodi M, La Spina C, Triolo G, et al.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2016; (254(7)):1275-9 doi:10.1007/s00417-015-3185-x.
PMID: 26472300 - 9
Differentiation of Underlying Pathologies of Macular Edema Using Spectral Domain Optical Coherence Tomography (SD-OCT).
Dysli M, Rückert R, Munk MR
Ocular immunology and inflammation 2019; (27(3)):474-483 doi:10.1080/09273948.2019.1603313.
PMID: 31184556 - 10
Detection of cystoid macular edema in patients with retinitis pigmentosa based on deep learning.
Hosseini F, Asadi F, Ahmadieh H, et al.
International journal of retina and vitreous 2025; (11(1)):139 doi:10.1186/s40942-025-00762-6.
PMID: 41444668 - 11
Bilateral Foveal Cysts in Mucopolysaccharidosis Type I (Hurler Syndrome): Response to Acetazolamide With Insights From Multimodal Retinal Imaging and Electrophysiology.
Lobo R, Al-Hinai A, Al Busaidi A
Case reports in ophthalmological medicine 2025; (2025()):5349202 doi:10.1155/crop/5349202.
PMID: 41312338 - 12
Unilateral pigmentary retinopathy: a retrospective case series.
Errera MH, Robson AG, Wong T, et al.
Acta ophthalmologica 2019; (97(4)):e601-e617 doi:10.1111/aos.13981.
PMID: 30597758 - 13
A hidden structural variation in a known IRD gene: a cautionary tale of two new disease candidate genes.
Scott HA, Larson A, Rong SS, et al.
Cold Spring Harbor molecular case studies 2022; (8(2)) doi:10.1101/mcs.a006131.
PMID: 34728537 - 14
Genetic dissection of non-syndromic retinitis pigmentosa.
Bhardwaj A, Yadav A, Yadav M, Tanwar M
Indian journal of ophthalmology 2022; (70(7)):2355-2385 doi:10.4103/ijo.IJO_46_22.
PMID: 35791117
This page explains the diagnostic tests for Retinitis Pigmentosa for educational purposes only. Always consult your ophthalmologist or retina specialist to interpret your specific eye exam and genetic test results.
Stay up to date
Get notified when new research about Retinitis pigmentosa is published.
No spam. Unsubscribe anytime.